Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor
about
Cardiac purinergic signalling in health and diseaseProgrammable nanoscaffolds that control ligand display to a G-protein-coupled receptor in membranes to allow dissection of multivalent effects.GPCR ligand-dendrimer (GLiDe) conjugates: future smart drugs?GPCR ligand dendrimer (GLiDe) conjugates: adenosine receptor interactions of a series of multivalent xanthine antagonistsAnti-ischemic effects of multivalent dendrimeric A₃ adenosine receptor agonists in cultured cardiomyocytes and in the isolated rat heart.The potential for nanotechnology to improve delivery of therapy to the acute ischemic heart.
P2860
Multivalent dendrimeric and monomeric adenosine agonists attenuate cell death in HL-1 mouse cardiomyocytes expressing the A(3) receptor
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Multivalent dendrimeric and mo ...... s expressing the A(3) receptor
@ast
Multivalent dendrimeric and mo ...... s expressing the A(3) receptor
@en
type
label
Multivalent dendrimeric and mo ...... s expressing the A(3) receptor
@ast
Multivalent dendrimeric and mo ...... s expressing the A(3) receptor
@en
prefLabel
Multivalent dendrimeric and mo ...... s expressing the A(3) receptor
@ast
Multivalent dendrimeric and mo ...... s expressing the A(3) receptor
@en
P2093
P2860
P1476
Multivalent dendrimeric and mo ...... s expressing the A(3) receptor
@en
P2093
Asher Shainberg
Athena M Keene
John Lloyd
Kenneth A Jacobson
Ramachandran Balasubramanian
P2860
P304
P356
10.1016/J.BCP.2010.03.020
P407
P577
2010-03-25T00:00:00Z